Virginia Tech® home

In Person Special Seminar: Involvement of Non-canonical Inflammatory Response in Tissue Dysfunction of Several Chronic Diseases

Insert your title here

David Crossman, Ph.D.

David Crossman, Ph.D.

Academic Director, Biomedical Research Imaging Unit
Senior Research Fellow, Heart Foundation of New Zealand
Cardiac Nanobiology Research Group
Department of Physiology
School of Medical Sciences
Waipapa Taumata Rau | The University of Auckland

In Person Seminar: Fibrosis and Aberrant Ca2+ Handling in the Failing Heart

Date: Feb. 15, 2024

Time:  11 a.m.

About this Seminar

Fibrosis and aberrant Ca2+ handling are hallmarks of heart failure but are considered separate features. However, the fibrotic disposition of nanometer-sized collagen fibrils, particularly collagen VI (ColVI), may directly diminish Ca2+signalling in human heart failure. Using super-resolution microscopy Dr. Crossman and his team found increased ColVI within the transverse(t)-tubules. Moreover, t-tubule remodeling disrupts Ca2+ signaling in heart failure. Recently, circulating levels of ColVI were found to independently associate with poor outcomes in heart failure. While the importance of ColVI to skeletal muscle function is underscored by its mutation causing muscular dystrophy, its role in cardiac contraction remains poorly understood. Significantly, muscular dystrophy patients often develop heart failure. To understand the role of ColVI in the heart the lab created a knockout of this gene in the rat (Col6a1-/-). Echocardiography showed both impaired systolic and diastolic function. Cardiac myocytes from Col6a1-/- have increased systolic Ca2+transient and greater response to b-adrenergic stimulation that is pro-arrhythmogenic. Similar disturbance in Ca2+ handling is found in the cardiac myocytes of the mdx mouse which has non-functional dystrophin supporting our hypothesis that ColVI is part of the dystrophin-glycoprotein-complex and may have a role in regulating Ca2+ dynamics.

You May Also Be Interested In...

  • Home Item
    The New Era in Alzheimer's Diagnosis and Treatment
    The New Era in Alzheimer's Diagnosis and Treatment , home

    May 14, 2026, 5:30 p.m. (Reception at 5 p.m.) | John C. Morris, M.D., Friedman Distinguished Professor of Neurology, Director, Knight Alzheimer Disease Research Center, Washington University School of Medicine | Maury Strauss Distinguished Public Lecture

  • Home Item
    Spatial Disorder in the Aging Brain
    Spatial Disorder in the Aging Brain , home

    May 15, 2026, 11 a.m. | Paul Laurienti, M.D., Ph.D., Professor, Department of Radiology, Wake Forest University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Human Neuroscience Research

  • Home Item
    Unraveling Mechanisms of BCAA Compartmentalization and Crosstalk in Cardiometabolic Disease
    Unraveling Mechanisms of BCAA Compartmentalization and Crosstalk in Cardiometabolic Disease , home

    May 29, 2026, 11:00 a.m. | Phillip J. White, Ph.D., Associate Professor of Medicine, Division of Endocrinology, Metabolism, & Nutrition, Duke Molecular Physiology Institute, Duke University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Exercise Medicine Research

  • Home Item
    The Symphonic Biology of Exercise
    The Symphonic Biology of Exercise , home

    June 4, 2026, 5:30 p.m. (Reception at 5 p.m.) | R. Sanders Williams, M.D., Professor and Dean Emeritus, School of Medicine, Senior Advisor for Science & Technology, Duke University | Maury Strauss Distinguished Public Lecture